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ABSTRACT Pregnancy requires a host of localized immune factors that allow the mother to tolerate the fetus.
Changes in the mother’s serum immunity during pregnancy are less well-known. To clarify these changes, 1,351 women
from the NHANES 1999–2000 were analyzed with complex survey regression to test the effect of pregnancy on adaptive
and innate immune markers. Adjusting for age and BMI, pregnant women had higher C-reactive protein levels and
white blood cell counts and lower measles antibody titer and lymphocyte counts than nonpregnant women. This dual
pattern of immunological changes supports the hypothesis that mothers will reduce the ability of the adaptive immune
system to respond to infection while increasing the activity of innate immunity during pregnancy, maintaining immune
function homeostasis. The function of these homeostatic immune responses is unknown. Am. J. Hum. Biol. 21:401–403,
2009. ' 2009 Wiley-Liss, Inc.
The evolutionary adaptation that allows the implanta-
tion of the embryo into the mothers womb is an immuno-
logical conundrum (Medawar, 1953). Since the fetus is not
genetically identical to its mother, it should be rejected by
her immune system; instead, most pregnancies are toler-
ated and brought fully to term. In humans, the placenta
mediates tolerance and many of the immune factors are
localized near this barrier.
On the maternal side of the placenta several main fac-
tors regulate immunity. There is a proliferation of macro-
phages and uterine natural killer cells that are thought to
play a significant role in toleration of the fetus. The com-
plement system is down-regulated to prevent inflamma-
tion. Finally, progesterone and estrogen promote local
anti-inflammatory responses that help prevent rejection
of the placenta. On the fetal side, major histocompatibility
complex molecules are either not expressed or altered in
appearance, causing most maternal T-cells to ignore the
placenta. In addition, the placenta produces some anti-
inflammatory effects. On both sides, there are a variety of
cytokines that regulate the uterine immune environment
(Poole and Claman, 2004).
To ensure the mother’s survival during pregnancy the
immune system patrolling the rest of the body cannot be
drastically altered. However, some researchers have noted
some changes in maternal immune function during preg-
nancy; specifically, studies indicate that the innate
immune system dominates the immune system, with
mixed evidence for adaptive immune system changes
(Luppi, 2003).
The purpose of this report is to analyze the changes in
peripheral immune function during pregnancy in a popu-
lation of American women. It will examine population dif-
ferences in pregnant versus nonpregnant women for four
serum immune factors: measles antibody titer, lympho-
cyte count, white blood cell (WBC) count, and C-reactive
protein (CRP) levels. I hypothesize that markers of innate
(nonspecific) immunity will be higher, and adaptive
(memory) immunity markers will be lower in pregnant
women compared with nonpregnant women, helping
maintain homeostasis during the immunological and
energetic changes associated with pregnancy.
METHODS
Sample
Data were taken from the National Health and Nutrition
Examination Survey 1999–2000 (National Center of Health
Statistics and Center for Disease Control and Prevention,
2007). The NHANES 1999–2000 set was compiled from
interviews, examinations, and laboratory tests of blood and
urine. Women between the ages of 18 and 49 who had non-
missing values for all dependent and independent variables
were included in the study subpopulation, leaving a total n
of 1,351 women out of a possible 5,082 women.
Variables
Four main dependent variables were assessed in this
study: measles antibody titer, C-reactive protein (CRP)
levels, lymphocyte count, and white blood cell (WBC)
minus lymphocyte count.
Measles antibody level reflects circulating amounts of
antibodies that are available to respond to the measles vi-
rus and reflects the ability of the adaptive humoral immu-
nity to respond to infection. CRP is an acute phase protein
that is implicated in the innate immune system and is
widely used as a marker of inflammation (Marnell et al.,
2005). Lymphocyte count is the total number of natural
killer cells, B-cells, and T-cells circulating in the blood.
The vast majority of lymphocytes are T-cells and B-cells,
with natural killer cells typically making up less than
20% of the total lymphocyte count (Chng et al., 2004).
Lymphocyte counts are elevated during viral infection
(Moghaddam et al., 1997), making them an indicator of
cell-mediated adaptive immunity. WBC count is used as a
clinical marker of innate immune function. In this study,
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WBC count was calculated as the total number of white
blood cells in the blood minus the lymphocyte count.
Women who had nonmissing values for CRP, WBC
count, lymphocyte count, and measles antibody titer were
included in the subpopulation. However, women who had
an optical density index for measles of <1.0, defined by
NHANES documentation as having no detectable antibod-
ies to measles, were excluded from analysis because the
data set did not contain the variables necessary to sepa-
rate women who had never been exposed to measles from
those that had been exposed, either through infection or
vaccination, but had below-threshold values. Measles
antibody and CRP levels (mg/dl) were log-transformed
and lymphocyte and WBC counts were square-root trans-
formed to normalize their distributions.
Pregnancy status was the main independent variable
for all four dependent variables. Women were categorized
as either pregnant or not pregnant based on the results
from a urine pregnancy test. Approximately 20% of preg-
nant women could not provide their month of pregnancy,
and so this variable was not included. Analyses were
adjusted for age and BMI.
Statistical methods
All analyses were performed in SAS 9.1. Means and fre-
quencies were calculated for both the total NHANES
female population and the subpopulation. They were com-
pared using z-tests to determine whether the subpopula-
tion characteristics are significantly different from total
population characteristics.
Following the procedures recommended by NHANES
1999–2000, the sample was weighted using appropriate 2-
year strata, cluster, and weight variables from the MEC
examination data set.
Sample weights and cluster variables require the entire
population to be analyzed to produce unbiased estimates.
Since individuals in the subpopulation may not be repre-
sented in all clusters and strata, the SAS macro
%SREGSUB was used to analyze the subpopulation while
Fig. 1. Differences between pregnant and nonpregnant women in measles antibody titer, lymphocyte count, white blood cell count, and
C-reactive protein.




Measles antibody 20.21* 0.032** 0.0028
C-reactive protein 0.80** 0.0084 0.11**
Lymphocyte count 20.12** 20.0033** 0.0061**
White blood cell count 0.42** 20.0060** 0.011**
*P < 0.05; **P < 0.0125.
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considering observations from the entire NHANES sam-
ple (SAS Institute Inc, 2002). This macro provides extra
capabilities that are not found in PROC SURVEYREG.
Specifically, it restricts regression analysis to a subpopula-
tion and incorporates missing values into variance compu-
tations in order to avoid incorrect estimates due to sub-
group bias.
The a in this study is 0.05. Because four dependent vari-
ables are tested a Bonferroni correction to 0.0125 (0.05/4)
is necessary to adjust the a level for each regression model
so that the overall a level is maintained. The PROC REG
procedure in SAS was used to determine that all variance
inflation factors did not exceed 1.5, far below the recom-
mended cutoff of 10 for determining the collinearity of var-
iables in a model (Belsley et al., 1980). Study power was
assessed using PROC POWER for multiple regression.
Using one test predictor and three full predictors, a sam-
ple size of 1,351, and a small effect size (0.1), the power of
each model is 95.8%.
RESULTS
Z-tests of study subpopulation characteristics versus
the entire NHANES sample of women show the following
comparisons. The subpopulation is not significantly differ-
ent from the total population in age (31.1 vs. 30.4 years, P
5 0.14), measles antibody level (10.8 vs. 10.6 ODI, P 5
0.17), and lymphocyte count (2.2 vs. 2.4 SI, P 5 1). The
subpopulation is significantly higher than the general
population in CRP levels (0.53 vs. 0.45 mg/dl, P 5 0.0008),
WBC counts (5.7 vs. 5.2 SI, P < 0.0001), BMI (28.4 vs.
25.5, P < 0.0001), and percentage of women pregnant
(16.9% vs. 6.0%, P 5 0.005). The subpopulation excluded
nonreproductive age women, explaining the higher per-
centage of pregnant women.
To examine if differences in BMI, CRP, and WBC count
were due to the higher proportion of pregnant women in
the sample, an adjusted subpopulation (n 5 1201) was
generated containing all nonpregnant women and a ran-
dom sample of 78 pregnant women from the subpopula-
tion to approximate the 6% pregnancy rate in the general
population. Z-tests indicate that CRP levels in the
adjusted subpopulation are not significantly different
than the general population (P 5 0.06); however, WBC
count and BMI remain significantly different (P < 0.0001
for both). Therefore, differences in CRP levels between the
subpopulation and the general population can be attrib-
uted to the higher proportion of pregnant women in the
sample, but differences in BMI and WBC count cannot.
A summary of regression coefficients and significance
levels of all multiple regression models can be found in
Table 1. There were significant differences between preg-
nant and nonpregnant women on three of the four depend-
ent variables: CRP levels, lymphocyte count, and WBC
count. The fourth dependent variable, measles antibody
titer, was significant at a 5 0.05, but did not meet the
more stringent Bonferroni-adjusted significance level. The
direction of these differences can be observed in Figure 1.
DISCUSSION
These results show an increase in biomarkers related to
innate immunity and a decrease in biomarkers related to
adaptive immunity during pregnancy. There are two pos-
sible explanations for this dual pattern. First, it could
allow the entire immune system to retain desirable levels
of immune system reactivity, neither underreacting nor
overreacting to threatening pathogens. It may also help
prevent a systemic immune overreaction to the fetus.
There may also be a second, energetic explanation.
Research indicates that the innate immune system is less
energetically costly to maintain than the adaptive
immune system (Lochmiller and Deerenberg, 2000).
Mothers may increase the activity of the innate immune
system and decrease the activity of the adaptive immune
system to reserve energy for pregnancy. Repeating this
study in both a nutritionally deficient population and a
high inflammation population, such as women with pree-
clampsia, may be able to help differentiate between these
two possibilities. In addition, more measures of immune
system activity, such as lymphocyte subset counts,
delayed hypersensitivity reactions, or response to vaccine,
can provide fine-tuned insight into the nature of immune
system trade-offs.
In sum, since pregnancy is accompanied by a vast array
of immunological changes that allow the mother to toler-
ate the fetus, the present dual pattern of immunological
activity supports the hypothesis that the immune system
regulates itself to maintain homeostasis. Mothers accom-
modate increases in their innate immune system activity
by lowering the ability of the adaptive immune system to
respond to infection. Further research should address pos-
sible causes for this phenomenon.
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